Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 2
Submit an article Journal homepage
1,723
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

Simona BramanteUniversity of Helsinki, Faculty of Medicine, Department of Pathology, Cancer Gene Therapy Group, Helsinki, Finland
,
Anniina KoskiUniversity of Helsinki, Faculty of Medicine, Department of Pathology, Cancer Gene Therapy Group, Helsinki, FinlandCorrespondence[email protected] [email protected]
,
Ilkka LiikanenUniversity of Helsinki, Faculty of Medicine, Department of Pathology, Cancer Gene Therapy Group, Helsinki, Finland
,
Lotta VassilevOncos Therapeutics Ltd., Helsinki, Finland
,
Minna OksanenUniversity of Helsinki, Faculty of Medicine, Department of Pathology, Cancer Gene Therapy Group, Helsinki, Finland
,
Mikko SiuralaUniversity of Helsinki, Faculty of Medicine, Department of Pathology, Cancer Gene Therapy Group, Helsinki, Finland;TILT Biotherapeutics Ltd., Helsinki, Finland
,
Raita HeiskanenOncos Therapeutics Ltd., Helsinki, Finland
,
Tiina HakonenOncos Therapeutics Ltd., Helsinki, Finland
,
Timo JoensuuDocrates Cancer Center, Helsinki, Finland
,
Anna KanervaUniversity of Helsinki, Faculty of Medicine, Department of Pathology, Cancer Gene Therapy Group, Helsinki, Finland;Helsinki University Central Hospital, Department of Obstetrics and Gynecology, Helsinki, Finland
,
Sari PesonenUniversity of Helsinki, Faculty of Medicine, Department of Pathology, Cancer Gene Therapy Group, Helsinki, Finland;Oncos Therapeutics Ltd., Helsinki, Finland
&
Akseli HemminkiUniversity of Helsinki, Faculty of Medicine, Department of Pathology, Cancer Gene Therapy Group, Helsinki, Finland;TILT Biotherapeutics Ltd., Helsinki, Finland;Helsinki University Central Hospital, Department of Oncology, Helsinki, FinlandCorrespondence[email protected] [email protected]
 show all
Article: e1078057 | Received 03 Jun 2015, Accepted 22 Jul 2015, Published online: 26 Feb 2016

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Shao-Chia Lu & Michael A Barry. (2022) Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses. Expert Opinion on Biological Therapy 22:11, pages 1359-1378.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
Abhishek D. Garg, Sanket More, Nicole Rufo, Odeta Mece, Maria Livia Sassano, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. OncoImmunology 6:12.
Read now
Antonela S. Asad, Mariela A. Moreno Ayala, M. Florencia Gottardo, Camila Zuccato, Alejandro Javier Nicola Candia, Flavia A. Zanetti, Adriana Seilicovich & Marianela Candolfi. (2017) Viral gene therapy for breast cancer: progress and challenges. Expert Opinion on Biological Therapy 17:8, pages 945-959.
Read now

Articles from other publishers (21)

Parisa Shiri Aghbash, Reyhaneh Rasizadeh, Amir Hossein Yari, Shiva Lahouti, Habib MotieGhader, Javid Sadri Nahand, Taher Entezari-Maleki & Hossein Bannazadeh Baghi. (2023) Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry 23:18, pages 2008-2026.
Crossref
Maryam Sadri, Alireza Najafi, Ali Rahimi, Nafiseh Behranvand, Mohammad Hossein Kazemi, Hossein Khorramdelazad & Reza Falak. (2023) Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?. International Immunopharmacology 122, pages 110470.
Crossref
Michael L. Monaco, Omer A. Idris & Karim Essani. (2023) Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses. Cancers 15:8, pages 2393.
Crossref
Mohammad Javanbakht, Sanaz Tahmasebzadeh, Luca Cegolon, Nasrin Gholami, Mandana Kashaki, Hassan Nikoueinejad, Mohamad Mozafari, Mahsa Mozaffari, Shi Zhao, Mostafa Khafaei, Morteza Izadi, Saeid Fathi & Reza Akhavan-Sigari. (2023) Oncolytic viruses: A novel treatment strategy for breast cancer. Genes & Diseases 10:2, pages 430-446.
Crossref
Yara Abdou, Atta Goudarzi, Jia Xin Yu, Samik Upadhaya, Benjamin Vincent & Lisa A. Carey. (2022) Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors. npj Breast Cancer 8:1.
Crossref
Amy Kwan, Faith Howard, Natalie Winder, Emer Atkinson, Ameera Jailani, Priya B. Patel, Richard Allen, Penelope D. Ottewell, Gary C. Shaw, Joe Conner, Caroline Wilson, Sanjay K. Srivastava, Sarah J. Danson, Claire Lewis, Janet E. Brown & Munitta Muthana. (2022) Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer. Future Pharmacology 2:4, pages 444-459.
Crossref
Nora A. Bahlmann, Raphael L. Tsoukas, Sebastian Erkens, Hongjie Wang, Franziska Jönsson, Malik Aydin, Ella A. Naumova, André Lieber, Anja Ehrhardt & Wenli Zhang. (2022) Properties of Adenovirus Vectors with Increased Affinity to DSG2 and the Potential Benefits of Oncolytic Approaches and Gene Therapy. Viruses 14:8, pages 1835.
Crossref
Chenyi Luo, Peipei Wang, Siqi He, Jingjing Zhu, Yuanyuan Shi & Jianxun Wang. (2022) Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer. Frontiers in Oncology 12.
Crossref
Dan Qiu, Guijuan Zhang, Xianxin Yan, Xinqin Xiao, Xinyi Ma, Shujun Lin, Jieyan Wu, Xinyuan Li, Wandi Wang, Junchen Liu, Yi Ma & Min Ma. (2022) Prospects of Immunotherapy for Triple-Negative Breast Cancer. Frontiers in Oncology 11.
Crossref
Mary E. Carter, André Koch, Ulrich M. Lauer & Andreas D. Hartkopf. (2021) Clinical Trials of Oncolytic Viruses in Breast Cancer. Frontiers in Oncology 11.
Crossref
Wesam Kooti, Hadi Esmaeili Gouvarchin Ghaleh, Mahdieh Farzanehpour, Ruhollah Dorostkar, Bahman Jalali Kondori & Masoumeh Bolandian. (2021) Oncolytic Viruses and Cancer, Do You Know the Main Mechanism?. Frontiers in Oncology 11.
Crossref
Shyambabu Chaurasiya & Yuman Fong. (2020) Viroimmunotherapy for breast cancer: promises, problems and future directions. Cancer Gene Therapy 28:7-8, pages 757-768.
Crossref
Amy Kwan, Natalie Winder & Munitta Muthana. (2021) Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances. Viruses 13:6, pages 1128.
Crossref
Benjamin Gordon & Vijayakrishna K. Gadi. (2020) The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines. Vaccines 8:3, pages 529.
Crossref
Cinzia Solinas, Marco Aiello, Edoardo Migliori, Karen Willard-Gallo & Leisha A. Emens. (2020) Breast cancer vaccines: Heeding the lessons of the past to guide a path forward. Cancer Treatment Reviews 84, pages 101947.
Crossref
Safieh Ebrahimi, Elnaz Ghorbani, Mojtaba Shafiee, Mikhail Ryzhikov, Seyed M Hassanian & Kayhan Azadmanesh. (2018) Therapeutic potency of oncolytic virotherapy in breast cancer targeting, current status and perspective. Journal of Cellular Biochemistry 120:3, pages 2801-2809.
Crossref
Rodolfo Garza-Morales, Roxana Gonzalez-Ramos, Akiko Chiba, Roberto Montes de Oca-Luna, Lacey McNally, Kelly McMasters & Jorge Gomez-Gutierrez. (2018) Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro. Cancers 10:5, pages 144.
Crossref
C. Yang, J. Zhang, M. Ding, K. Xu, L. Li, L. Mao & J. Zheng. (2017) Ki67 targeted strategies for cancer therapy. Clinical and Translational Oncology 20:5, pages 570-575.
Crossref
Yan Li, JinWoo Hong, Joung-Eun Oh, A-Rum Yoon & Chae-Ok Yun. (2018) Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer. International Journal of Cancer 142:2, pages 392-413.
Crossref
Yangyang Liu, Feifei Gu, Jinyan Liang, Xiaomeng Dai, Chao Wan, Xiaohua Hong, Kai Zhang & Li Liu. (2017) The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis. PLOS ONE 12:3, pages e0173693.
Crossref
Yogesh R. Suryawanshi, Tiantian Zhang & Karim Essani. (2017) Oncolytic viruses: emerging options for the treatment of breast cancer. Medical Oncology 34:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.